Maria A. Ahonen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria A. Ahonen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Nidhina Haridas Pachakkil Antharaparambath
Minerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland
2 shared publications - Vesa M. Olkkonen
Minerva Foundation Institute for Medical Research, Helsinki, Finland
2 shared publications - Eija Jokitalo
Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
1 shared publication - Francisco Jose Ortega
Department of Diabetes, Endocrinology and Nutrition, Institut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Spain
1 shared publication - Gerhard Liebisch
Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg, Germany
1 shared publication - Hanna Savolainen-Peltonen
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital , Helsinki FI-00290
1 shared publication
Latest Publications
- Open Access
- 7 August 2022
- Published by Elsevier in Journal of Lipid Research
- Vol. 63 (9) , 100259
GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth
- 7 August 2022
- Published by Elsevier in Journal of Lipid Research
- Vol. 63 (9) , 100259
Open AccessGOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth
- Open Access
- 30 August 2017
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 102 (11) , 4001-4012
MicroRNA-221-3p Regulates Angiopoietin-Like 8 (ANGPTL8) Expression in Adipocytes
Context Angiopoietin-like 8 (ANGPTL8) has been identified as a key regulator of lipid metabolism. Design We addressed the correlation between ANGPTL8 mRNA with hallmark insulin-regulated and lipogenic genes in human adipose tissue. The regulation of ANGPTL8 expression in adipocytes was studied after inflammatory challenge, and the role of microRNA-221-3p therein was investigated. Results ANGPTL8 gene expression in subcutaneous (SAT) and visceral (VAT) adipose tissue was highly correlated with SLC2A4/GLUT4 and ADIPOQ/Adiponectin. ANGPTL8 mRNA in human adipocytes was suppressed by the inflammatory impact of conditioned medium of lipopolysaccharide-stimulated macrophages, which markedly induced miR-221-3p. miR-221-3p was shown to target the ANGPTL8 mRNA, and to reduce adipocyte ANGPTL8 protein expression. Analysis of SAT biopsies from 69 subjects ranging from lean to morbidly obese, and of VAT of 19 female subjects biopsied during gynecologic surgery, demonstrated a trend of negative correlation between ANGPTL8 and miR-221-3p. Significant negative correlation of ANGPTL8 and miR-221-3p was identified in pre-surgery SAT samples from 22 morbidly obese subjects undergoing bariatric surgery, but vanished after ∼2-year surgery-induced weight loss, which also resulted in a marked reduction of miR-221-3p. ANGPTL8 correlated negatively with the AT inflammatory gene phospholipase A2 G7 (PLA2G7), while miR-221-3p showed a significant positive correlation with this marker. Of note, no correlation was found between adipose tissue ANGPTL8 mRNA expression and plasma ANGPTL8. Conclusions The inflammation-induced miR-221-3p regulates ANGPTL8 expression in adipocytes. This miRNA impact may become especially prominent under pathologic conditions such as morbid obesity, putatively contributing to the impaired AT lipid metabolism in metabolic disease.
- 30 August 2017
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 102 (11) , 4001-4012
Open AccessMicroRNA-221-3p Regulates Angiopoietin-Like 8 (ANGPTL8) Expression in Adipocytes
Context Angiopoietin-like 8 (ANGPTL8) has been identified as a key regulator of lipid metabolism. Design We addressed the correlation between ANGPTL8 mRNA with hallmark insulin-regulated and lipogenic genes in human adipose tissue. The regulation of ANGPTL8 expression in adipocytes was studied after inflammatory challenge, and the role of microRNA-221-3p therein was investigated. Results ANGPTL8 gene expression in subcutaneous (SAT) and visceral (VAT) adipose tissue was highly correlated with SLC2A4/GLUT4 and ADIPOQ/Adiponectin. ANGPTL8 mRNA in human adipocytes was suppressed by the inflammatory impact of conditioned medium of lipopolysaccharide-stimulated macrophages, which markedly induced miR-221-3p. miR-221-3p was shown to target the ANGPTL8 mRNA, and to reduce adipocyte ANGPTL8 protein expression. Analysis of SAT biopsies from 69 subjects ranging from lean to morbidly obese, and of VAT of 19 female subjects biopsied during gynecologic surgery, demonstrated a trend of negative correlation between ANGPTL8 and miR-221-3p. Significant negative correlation of ANGPTL8 and miR-221-3p was identified in pre-surgery SAT samples from 22 morbidly obese subjects undergoing bariatric surgery, but vanished after ∼2-year surgery-induced weight loss, which also resulted in a marked reduction of miR-221-3p. ANGPTL8 correlated negatively with the AT inflammatory gene phospholipase A2 G7 (PLA2G7), while miR-221-3p showed a significant positive correlation with this marker. Of note, no correlation was found between adipose tissue ANGPTL8 mRNA expression and plasma ANGPTL8. Conclusions The inflammation-induced miR-221-3p regulates ANGPTL8 expression in adipocytes. This miRNA impact may become especially prominent under pathologic conditions such as morbid obesity, putatively contributing to the impaired AT lipid metabolism in metabolic disease.